New Fetal Dose Estimates from super( 18)F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms

Data from the literature show that the fetal absorbed dose from super( 18)F-FDG administration to the pregnant mother ranges from 0.5E-2 to 4E-2 mGy/MBq. These figures were, however, obtained using different quantification techniques and with basic geometric anthropomorphic phantoms. The aim of this...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of nuclear medicine (1978) Vol. 57; no. 11; p. 1760
Main Authors: Zanotti-Fregonara, Paolo, Chastan, Mathieu, Edet-Sanson, Agathe, Ekmekcioglu, Ozgul, Erdogan, Ezgi Basak, Hapdey, Sebastien, Hindie, Elif, Stabin, Michael G
Format: Journal Article
Language:English
Published: 01-11-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Data from the literature show that the fetal absorbed dose from super( 18)F-FDG administration to the pregnant mother ranges from 0.5E-2 to 4E-2 mGy/MBq. These figures were, however, obtained using different quantification techniques and with basic geometric anthropomorphic phantoms. The aim of this study was to refine the fetal dose estimates of published as well as new cases using realistic voxel-based phantoms. Methods: The super( 18)F-FDG doses to the fetus (n = 19; 5-34 wk of pregnancy) were calculated with new voxel-based anthropomorphic phantoms of the pregnant woman. The image-derived fetal time-integrated activity values were combined with those of the mothers' organs from the International Commission on Radiological Protection publication 106 and the dynamic bladder model with a 1-h bladder-voiding interval. The dose to the uterus was used as a proxy for early pregnancy (up to 10 wk). The time-integrated activities were entered into OLINDA/EXM 1.1 to derive the dose with the classic anthropomorphic phantoms of pregnant women, then into OLINDA/EXM 2.0 to assess the dose using new voxel-based phantoms. Results: The average fetal doses (mGy/MBq) with OLINDA/EXM 2.0 were 2.5E-02 in early pregnancy, 1.3E-02 in the late part of the first trimester, 8.5E-03 in the second trimester, and 5.1E-03 in the third trimester. The differences compared with the doses calculated with OLINDA/EXM 1.1 were +7%, +70%, +35%, and -8%, respectively. Conclusion: Except in late pregnancy, the doses estimated with realistic voxelwise anthropomorphic phantoms are higher than the doses derived from old geometric phantoms. The doses remain, however, well below the threshold for any deterministic effects. Thus, pregnancy is not an absolute contraindication of a clinically justified super( 18)F-FDG PET scan.
AbstractList Data from the literature show that the fetal absorbed dose from super( 18)F-FDG administration to the pregnant mother ranges from 0.5E-2 to 4E-2 mGy/MBq. These figures were, however, obtained using different quantification techniques and with basic geometric anthropomorphic phantoms. The aim of this study was to refine the fetal dose estimates of published as well as new cases using realistic voxel-based phantoms. Methods: The super( 18)F-FDG doses to the fetus (n = 19; 5-34 wk of pregnancy) were calculated with new voxel-based anthropomorphic phantoms of the pregnant woman. The image-derived fetal time-integrated activity values were combined with those of the mothers' organs from the International Commission on Radiological Protection publication 106 and the dynamic bladder model with a 1-h bladder-voiding interval. The dose to the uterus was used as a proxy for early pregnancy (up to 10 wk). The time-integrated activities were entered into OLINDA/EXM 1.1 to derive the dose with the classic anthropomorphic phantoms of pregnant women, then into OLINDA/EXM 2.0 to assess the dose using new voxel-based phantoms. Results: The average fetal doses (mGy/MBq) with OLINDA/EXM 2.0 were 2.5E-02 in early pregnancy, 1.3E-02 in the late part of the first trimester, 8.5E-03 in the second trimester, and 5.1E-03 in the third trimester. The differences compared with the doses calculated with OLINDA/EXM 1.1 were +7%, +70%, +35%, and -8%, respectively. Conclusion: Except in late pregnancy, the doses estimated with realistic voxelwise anthropomorphic phantoms are higher than the doses derived from old geometric phantoms. The doses remain, however, well below the threshold for any deterministic effects. Thus, pregnancy is not an absolute contraindication of a clinically justified super( 18)F-FDG PET scan.
Author Erdogan, Ezgi Basak
Hapdey, Sebastien
Ekmekcioglu, Ozgul
Hindie, Elif
Zanotti-Fregonara, Paolo
Edet-Sanson, Agathe
Stabin, Michael G
Chastan, Mathieu
Author_xml – sequence: 1
  givenname: Paolo
  surname: Zanotti-Fregonara
  fullname: Zanotti-Fregonara, Paolo
– sequence: 2
  givenname: Mathieu
  surname: Chastan
  fullname: Chastan, Mathieu
– sequence: 3
  givenname: Agathe
  surname: Edet-Sanson
  fullname: Edet-Sanson, Agathe
– sequence: 4
  givenname: Ozgul
  surname: Ekmekcioglu
  fullname: Ekmekcioglu, Ozgul
– sequence: 5
  givenname: Ezgi
  surname: Erdogan
  middlename: Basak
  fullname: Erdogan, Ezgi Basak
– sequence: 6
  givenname: Sebastien
  surname: Hapdey
  fullname: Hapdey, Sebastien
– sequence: 7
  givenname: Elif
  surname: Hindie
  fullname: Hindie, Elif
– sequence: 8
  givenname: Michael
  surname: Stabin
  middlename: G
  fullname: Stabin, Michael G
BookMark eNqVjUFOwzAQRb0oEi1wh1mWRSRbyG3ErjQNrFAlENtqlEwaI9sTPI4KXIlLUhU4AKuv__X0_kxNIkeaqKk2C1NYq-25mom8aq0XZVlO1dcjHaCmjB4qFoKNZBcwk0CXOICMA6U5mPK6LurqHlZtcNFJpkQtVGNycQ_bRPuIsfm4haeMscXUuk_MjiNw92Ndo29Gf9oEjsjfzakfXO7hhd_JF3coR-8q5j7xwIHT0LsGtj3GzEEu1VmHXujqNy_UvN48rx-KIfHbSJJ3wUlD3mMkHmVnSquXS2OtufkH-g1yVWUG
ContentType Journal Article
DBID 7QO
8FD
FR3
P64
DatabaseName Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList Biotechnology Research Abstracts
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 1760
GroupedDBID ---
-~X
.55
29L
2WC
53G
5RE
7QO
8FD
8R4
8R5
8WZ
A6W
ABSQV
ACGOD
ACIWK
ACPRK
ADDZX
AENEX
AFOSN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DU5
E3Z
EBD
EBS
EJD
EMOBN
F5P
F9R
FR3
H13
I-F
INIJC
KQ8
L7B
OK1
P2P
P64
Q2X
R0Z
RHF
RHI
RNS
RWL
SJN
SV3
TAE
TR2
TSM
TUS
W8F
WH7
WOQ
X7M
YHG
ID FETCH-proquest_miscellaneous_18507715513
ISSN 0161-5505
IngestDate Fri Oct 25 07:44:21 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-proquest_miscellaneous_18507715513
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-2
PQID 1850771551
PQPubID 23462
ParticipantIDs proquest_miscellaneous_1850771551
PublicationCentury 2000
PublicationDate 20161101
PublicationDateYYYYMMDD 2016-11-01
PublicationDate_xml – month: 11
  year: 2016
  text: 20161101
  day: 01
PublicationDecade 2010
PublicationTitle The Journal of nuclear medicine (1978)
PublicationYear 2016
SSID ssj0006888
Score 4.4881363
Snippet Data from the literature show that the fetal absorbed dose from super( 18)F-FDG administration to the pregnant mother ranges from 0.5E-2 to 4E-2 mGy/MBq. These...
SourceID proquest
SourceType Aggregation Database
StartPage 1760
Title New Fetal Dose Estimates from super( 18)F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms
URI https://search.proquest.com/docview/1850771551
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELbaPSBe0PglYIAOCaShytK8hsTlbSwJQ4wNqQVNvFRu4pSyNkFtIiH-Jf5J7hzHtcYD44GXKHEiR_V9sT9f775j7HlQYDvNfnlUKB4EWc7VqBB8KA9ySXLigZHMPxlHZxcyToKk1-tKGm7b_qulsQ1tTZmz_2Bt1yk24DnaHI9odTxey-4UsJhqSnGMKRQ9wU94RXyyTSTZNN_JRnIg5IvDUcrT-K3Tz6WqnYO4TVv8uNZzkuIwelBj626wKZvEL03fx2qZNV0sHTng7cvMtXHwfq5-6CV_gytlPuhKMqwqNK2pukP1i61Y-rctaD2KXJLYslq7AACjKoUbUs998UWVVV0veEq5NqUyVZOQFuOU7gUuEANuE5PqrwvduF1Erms-Vl3629Gc2LC7ebnSl9mimi8bunn-c25DKK2LRIQ2V9DzmoaC01bMn_ZbXewO3sKbxEXUljiwhGB76Yt1n51P00-np9NJcjHps_5QUDxp_O69owGhNEVP3bv_WOwNg5nsslt2XOGoxcxt1tPlHXbjgx3bu-wXQgcMdIDMCw46QNABA519EPKlgQ34sIEWNuBg8xqugAaqou3VBw3gI-CBBgg04IEGroAGOtDcY_tpMjk-4d2PneJ8RX9CqVJXzWaK_PAgikxdoftsp6xK_YDBLBNS6UziUA8DrWajQ1w2ZDQM81C9mhXyIXv21-4eXeOZPXZzi4_HbKdeN_oJ62_y5qkx3m8L14o2
link.rule.ids 315,782,786
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+Fetal+Dose+Estimates+from+super%28+18%29F-FDG+Administered+During+Pregnancy%3A+Standardization+of+Dose+Calculations+and+Estimations+with+Voxel-Based+Anthropomorphic+Phantoms&rft.jtitle=The+Journal+of+nuclear+medicine+%281978%29&rft.au=Zanotti-Fregonara%2C+Paolo&rft.au=Chastan%2C+Mathieu&rft.au=Edet-Sanson%2C+Agathe&rft.au=Ekmekcioglu%2C+Ozgul&rft.date=2016-11-01&rft.issn=0161-5505&rft.volume=57&rft.issue=11&rft.spage=1760&rft.epage=1760&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-5505&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-5505&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-5505&client=summon